与肠道病毒脑膜炎相关的呼吸系统恶化,新生儿接受高流量鼻治疗
Rei Sato1, Takuma Ohnishi1, Mizue Tomita1
1Department of Pediatrics, National Hospital Organization (NHO) Saitama Hospital, Wako, JPN.
Cureus
|February 25, 2026
概括
高流量鼻腔管 (HFNC) 疗法有效地治疗了患有肠病毒脑膜炎的婴儿中枢低通风. 这种非侵入性方法稳定了呼吸功能,可能防止需要机械通风.
科学领域:
- 儿科 儿科 儿科
- 传染性疾病 传染性疾病
- 呼吸系统医学 呼吸系统医学
背景情况:
- 肠道病毒性脑膜炎通常影响婴儿,但中央低通风是一种未被认可的并发症.
- 标准的氧气疗法可能不足以治疗严重病例的呼吸系统恶化.
研究的目的:
- 报告一种肠道病毒性脑膜炎病例,中心低通风由高流鼻管 (HFNC) 治疗来管理.
- 突出HFNC作为潜在的非侵入性治疗呼吸道损害在这种情况下.
主要方法:
- 一个新生儿被诊断患有肠道病毒性脑膜炎 (Coxsackievirus B2) 的病例报告.
- 有记录的呼吸系统衰退,包括低氧化,勃拉迪普尼亚和高头,对常规氧气无反应.
- 启动和监测HFNC治疗.
主要成果:
- HFNC治疗迅速改善了婴儿的呼吸率和氧气和.
- 新生儿的呼吸状况稳定,不需要输管或机械通风.
结论:
- 在感染病毒性脑膜炎的婴儿中,HFNC是一种有前途的非侵入性选择,用于管理病毒性脑膜炎的婴儿的中心低通风.
- 潜在的好处包括正气道压力,死亡空间减少和呼吸驱动的调节.
- 在类似的儿科病例中,早期实施HFNC可能会避免侵入性通风.
相关概念视频
Acute Respiratory Failure-II
1.3K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
Acute Respiratory Failure-III
1000
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1000
Acute Respiratory Failure-V
551
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
551
Acute Respiratory Failure-IV
618
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
618
Acute Respiratory Failure-I
1.2K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.2K
Pneumonia IV: Management
868
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
868


